Velavan Thirumalaisamy P, Pallerla Srinivas Reddy, Rüter Jule, Augustin Yolanda, Kremsner Peter G, Krishna Sanjeev, Meyer Christian G
Institute of Tropical Medicine, Universitätsklinikum Tübingen, Wilhelmstrasse 27, Tübingen 72074, Germany; Vietnamese-German Center for Medical Research, VG-CARE, Hanoi, Vietnam.
Institute of Tropical Medicine, Universitätsklinikum Tübingen, Wilhelmstrasse 27, Tübingen 72074, Germany; Vietnamese-German Center for Medical Research, VG-CARE, Hanoi, Vietnam.
EBioMedicine. 2021 Oct;72:103629. doi: 10.1016/j.ebiom.2021.103629. Epub 2021 Oct 13.
The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) poses an unprecedented challenge to humanity. SARS-CoV-2 infections range from asymptomatic to severe courses of COVID-19 with acute respiratory distress syndrome (ARDS), multiorgan involvement and death. Risk factors for disease severity include older age, male sex, increased BMI and pre-existing comorbidities. Ethnicity is also relevant to COVID-19 susceptibility and severity. Host genetic predisposition to COVID-19 is now increasingly recognized and whole genome and candidate gene association studies regarding COVID-19 susceptibility have been performed. Several common and rare variants in genes related to inflammation or immune responses have been identified. We summarize research on COVID-19 host genetics and compile genetic variants associated with susceptibility to COVID-19 and disease severity. We discuss candidate genes that should be investigated further to understand such associations and provide insights relevant to pathogenesis, risk classification, therapy response, precision medicine, and drug repurposing.
由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的新型冠状病毒肺炎(COVID-19)大流行给人类带来了前所未有的挑战。SARS-CoV-2感染的范围从无症状到出现严重的COVID-19病程,伴有急性呼吸窘迫综合征(ARDS)、多器官受累及死亡。疾病严重程度的风险因素包括老年、男性、体重指数(BMI)增加和既往合并症。种族也与COVID-19的易感性和严重程度相关。目前,宿主对COVID-19的遗传易感性越来越受到认可,并且已经开展了关于COVID-19易感性的全基因组和候选基因关联研究。已经鉴定出与炎症或免疫反应相关基因中的几个常见和罕见变异。我们总结了关于COVID-19宿主遗传学的研究,并汇编了与COVID-19易感性和疾病严重程度相关的遗传变异。我们讨论了为理解此类关联应进一步研究的候选基因,并提供了与发病机制、风险分类、治疗反应、精准医学和药物再利用相关的见解。